Roosevelt Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $13.6M | Hold |
42,114
| – | – | 0.98% | 40 |
|
|
2022
Q2 | $13.7M | Hold |
42,114
| – | – | 0.98% | 37 |
|
|
2022
Q1 | $12.1M | Hold |
42,114
| – | – | 0.72% | 42 |
|
|
2021
Q4 | $11.6M | Hold |
42,114
| – | – | 0.64% | 48 |
|
|
2021
Q3 | $9.73M | Sell |
42,114
-1
| -0% | -$247 | 0.6% | 50 |
|
|
2021
Q2 | $9.67M | Buy |
42,115
+193
| +0.5% | +$38.8K | 0.58% | 50 |
|
|
2021
Q1 | $7.83M | Buy |
41,922
+129
| +0.3% | +$25.2K | 0.51% | 49 |
|
|
2020
Q4 | $7.06M | Buy |
41,793
+315
| +0.8% | +$47K | 0.5% | 51 |
|
|
2020
Q3 | $6.14M | Buy |
41,478
+38,700
| +1,393% | +$5.99M | 0.5% | 50 |
|
|
2020
Q2 | $456K | Buy |
2,778
+225
| +9% | +$34.5K | 0.05% | 112 |
|
|
2020
Q1 | $354K | Hold |
2,553
| – | – | 0.04% | 107 |
|
|
2019
Q4 | $336K | Hold |
2,553
| – | – | 0.03% | 127 |
|
|
2019
Q3 | $286K | Buy |
2,553
+107
| +4% | +$11.9K | 0.03% | 131 |
|
|
2019
Q2 | $271K | Sell |
2,446
-169
| -6% | -$19.9K | 0.03% | 128 |
|
|
2019
Q1 | $339K | Sell |
2,615
-133
| -5% | -$16.2K | 0.04% | 119 |
|
|
2018
Q4 | $318K | Sell |
2,748
-116
| -4% | -$13K | 0.03% | 158 |
|
|
2018
Q3 | $307K | Sell |
2,864
-74
| -3% | -$7.4K | 0.03% | 133 |
|
|
2018
Q2 | $251K | Hold |
2,938
| – | – | 0.02% | 142 |
|
|
2018
Q1 | $227K | Sell |
2,938
-920
| -24% | -$74.1K | 0.02% | 159 |
|
|
2017
Q4 | $326K | Buy |
3,858
+230
| +6% | +$19.6K | 0.03% | 149 |
|
|
2017
Q3 | $310K | Buy |
3,628
+445
| +14% | +$36.5K | 0.03% | 158 |
|
|
2017
Q2 | $262K | Sell |
3,183
-20
| -0.6% | -$1.63K | 0.02% | 170 |
|
|
2017
Q1 | $269K | Buy |
3,203
+72
| +2% | +$5.77K | 0.02% | 176 |
|
|
2016
Q4 | $230K | Buy |
3,131
+180
| +6% | +$13.4K | 0.02% | 179 |
|
|
2016
Q3 | $237K | Hold |
2,951
| – | – | 0.02% | 169 |
|
|
2016
Q2 | $232K | Buy |
2,951
+5
| +0.2% | +$376 | 0.02% | 180 |
|
|
2016
Q1 | $212K | Sell |
2,946
-53,292
| -95% | -$4.03M | 0.02% | 165 |
|
|
2015
Q4 | $4.74M | Buy |
56,238
+7,994
| +17% | +$663K | 0.31% | 56 |
|
|
2015
Q3 | $4.04M | Buy |
48,244
+6,045
| +14% | +$510K | 0.26% | 68 |
|
|
2015
Q2 | $3.52M | Sell |
42,199
-291
| -0.7% | -$22.2K | 0.21% | 78 |
|
|
2015
Q1 | $3.09M | Sell |
42,490
-1,108
| -3% | -$78.9K | 0.17% | 77 |
|
|
2014
Q4 | $3.01M | Sell |
43,598
-507
| -1% | -$34.2K | 0.17% | 82 |
|
|
2014
Q3 | $2.86M | Buy |
44,105
+150
| +0.3% | +$9.5K | 0.15% | 83 |
|
|
2014
Q2 | $2.73M | Sell |
43,955
-531,644
| -92% | -$31.7M | 0.12% | 79 |
|
|
2014
Q1 | $33.9M | Sell |
575,599
-184,629
| -24% | -$10.3M | 1.57% | 29 |
|
|
2013
Q4 | $38.8M | Sell |
760,228
-242,538
| -24% | -$12.1M | 1.75% | 22 |
|
|
2013
Q3 | $50.5M | Sell |
1,002,766
-43,175
| -4% | -$2.26M | 2.24% | 16 |
|
|
2013
Q2 | $51.4M | Buy |
+1,045,941
| New | +$56.9M | 2.31% | 8 |
|
Other funds holding LLY
Roosevelt Investment Group's LLY Position: Q3 2022 in Review
Roosevelt Investment Group held its Eli Lilly (LLY) position steady in Q3 2022 at 42,114 shares worth $13.6M. The position accounts for 0.98% of the portfolio, ranked #40.
Roosevelt Investment Group first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $51.4M in Q2 2013. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Roosevelt Investment Group held 42,114 shares of Eli Lilly worth $13.6M as of Q3 2022.
- Roosevelt Investment Group left its Eli Lilly share count unchanged in Q3 2022.
- Eli Lilly made up 0.98% of Roosevelt Investment Group's portfolio in Q3 2022, its #40 holding.
- Roosevelt Investment Group first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- Roosevelt Investment Group's Eli Lilly position peaked at $51.4M in Q2 2013.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.